ABSTRACT Pseidomonas exotoxin (PE), a single-chain polypeptide toxin of 613 amino acids, consists of three fuinctional domains: an amino-terminal receptor-binding domain, a middle translocation domain, and a carboxyl-terminal ADPribosylation domain. Deletion of as few as 2 or as many as 11 amino acids from the carboxyl terminus of PE does not affect ADP-ribosylation activity but produces noncytotoxic. molecules. Deletions and substitutions between positions 602 and 611 of PE show that the -last 5 amino acids of PE are very important for its cytotoxic action. The carboxyl-terminal sequence of PE is Arg-Glu-Asp-Leu-Lys. Mutational have been shown to be important for ADPribosylation activity (6-8). Recently, mutational analysis of domain II has shown that certain portions of this domain are absolutely required for the cytotoxicity of PE as well as a chimeric toxin made up of transforming growth factor a (TGFa) and a portion of PE (9, 10). In particular, the arginines at positions 276 and 279 are required for the cytotoxicity of PE (9).
activity. Lysine at 613 can be deleted or replaced with arginine but not with several other amino acids. Mutant toxins are able to bind normally to target Swiss mouse 3T3 cells and are internalized by endocytosis, but apparently they do not penetrate into the cytosol. A PE molecule that ends with LysAsp-Glu-Leu, which is a well defined endoplasmic reticulum retention sequence [Munro, S. and Pelham, R. B. (1987) Cell 48, 899-9071, is fully cytotoxic, suggesting that a common factor may be involved in intoxication of cells by PE and retention ofproteins in the lumen ofthe endoplasmic reticulum. Sequences similar to those at the carboxyl end of PE are also found at the end of Cholera toxin A chain and Escherichia coli heat-labile toxin A chain.
The mechanism by which protein toxins kill cells is quite complex. Many toxins bind to receptors on the surface of mammalian cells, are internalized by endocytosis, translocate to the cytosol, and there exert an enzymatic activity that kills the target cell (for review, see ref. 1) . Accordingly, these toxins have separate domains for cell binding, translocation, and an enzymatic activity that inactivates an essential cellular function. Pseudomonas exotoxin A (PE) is a single polypeptide chain of 613 amino acids (2) . X-ray crystallographic studies and mutational analysis of the PE molecule (3, 4) have shown that PE-consists of three domains; an amino-terminal cell receptor-binding domain (domain I), a middle translocation domain (domain II), and a carboxyl-terminal activity domain (domain III). Domain III catalyzes the ADPribosylation and inactivation of elongation factor.2, which inhibits protein synthesis and leads to cell death. Mutational analysis of domain I has revealed that Lys-57 plays a major role in receptor binding (5) . Similarly Glu-553, Tyr-481, and His-426 have been shown to be important for ADPribosylation activity (6) (7) (8) . Recently, mutational analysis of domain II has shown that certain portions of this domain are absolutely required for the cytotoxicity of PE as well as a chimeric toxin made up of transforming growth factor a (TGFa) and a portion of PE (9, 10) . In particular, the arginines at positions 276 and 279 are required for the cytotoxicity of PE (9) .
While constructing various chimeric toxins in which growth factors were fused to a form of PE (PE40) that was devoid of domain I, we observed that the recombinant fusion proteins made by attaching TGFa, interleukin 2 (IL2), or interleukin 4 (IL4) at the carboxyl end of PE40 had poor cytotoxic activity. PE40-TGFa was about 40-fold less active than TGFa-PE40 (11, 12) , and PE40-IL2 and PE40-IL4 were inactive in killing target cells (unpublished results). Furthermore, immunoconjugates made from PE40 were less cytotoxic than anticipated, probably due to conjugation of the antibody with one of the three lysine residues present near the carboxyl end of domain III (13) . These observations led us to examine the possibility that the carboxyl terminus of the activity domain of PE, domain III, may have an additional role in the cytotoxic action of PE. Here we present evidence that the carboxyl-terminal 5 amino acids of PE (ArgGlu-Asp-Leu-Lys, REDLK) have important information for the cytotoxicity of PE that is unrelated to ADP-ribosylation. Similar sequences are also found at the carboxyl end of Escherichia coli heat-labile toxin (14) and Cholera toxin A chain (15) . The sequence REDLK may be a recognition sequence required for entry of the ADP-ribosylation domain of PE into the cytosol.
MATERIALS AND METHODS
Materials. Sources of most reagents have been described (11, 16) . The polymerase chain reaction (PCR) was performed using a GeneAmp kit (Perkin-Elmer/Cetus).
Mutants and Plasmid Constructions. Mutants were created by oligonucleotide-directed mutagenesis using plasmid pVC45f+T as described (5, 9) or using PCR as described below. pVC45f+T carries a PE gene under control of a T7 promoter and also contains a T7 transcriptional terminator and an fl phage origin (9, 16) . The PE-gene in this plasmid contains an OmpA signal sequence that is cleaved upon secretion of PE into the periplasm, leaving a 3-amino acid (Ala-Asn-Leu) extension at the amino terminus (17) . For (9) . Internalization of various mutant PE derivatives was studied by immunofluorescence as described (9) . 1-612 100 100 Mutant PE proteins were expressed in E. coli using a T7 promoterbased vector (16) and purified from the periplasm. All proteins contain a 3-amino acid (Ala-Asn-Leu) amino-terminal extension remaining after the processing of the OmpA signal sequence. These amino acids were not considered when assigning residue numbers to the mutant proteins. Cytotoxicity was determined by assaying inhibition of protein synthesis on Swiss mouse 3T3 cells. All results are expressed as percent of the activity obtained with recombinant full-length PE (amino acids 1-613). All the assays were done in duplicate and at least two separate clones were tested. *A means deletion of the indicated amino acid(s).
RESULTS
To investigate the role of amino acid residues at the carboxyl end of PE, a series of terminal deletion mutants were constructed that removed 1, 2, 3, 7, 8, 11, 14, and 24 amino acids. Removal of 2 or more amino acids eliminated cytotoxicity without affecting ADP-ribosylation activity (Table 1, Fig. 1 ). In fact, even 11 amino acids (A603-613) could be removed without any loss of ADP-ribosylation activity. However, removal of 14 amino acids (A600-613) resulted in a protein with low but measurable ADP-ribosylation activity, and removal of 24 amino acids (A590-613) produced an enzymatically inactive protein. These results indicate that residues at the carboxyl end of PE have a role in toxin action and that these residues are not involved in the ADP-ribosylation reaction.
The role of the carboxyl-terminal residues in toxin action was further defined by creating a series of internal deletions and substitutions (Table 2 ). These mutations began at amino acid 602, so that ADP-ribosylating activity would not be 
Mutant PE proteins were expressed in E. coli and purified from the periplasm. ADP Table 1 showing that deletion of amino acids 612 and 613 abolishes cytotoxicity, focused our attention on amino acids 609-613, which are situated at the carboxyl terminus of PE.
The role of Arg-609 was studied by either deleting it or replacing it with several different amino acids. Replacement with another basic amino acid, lysine, did not reduce the cytotoxic activity ofPE (Table 3) . However, deleting Arg-609 (pVC49115) or replacing it with glycine, glutamic acid, or leucine reduced cytotoxicity by a factor of 6-10. Thus, a basic amino acid appears to be important at position 609. To study the sequence specificity of the last 5 amino acids of PE, several other mutant molecules were then constructed. In two of these, the order of the acidic amino acids at positions 610 and 611 was reversed and Lys-613 was deleted (Table 4 , pVC49415 and pVC49425). These molecules were fully active whether residue 609 was a lysine or an arginine. We also created a molecule with a leucine at position 609 and an arginine at 612 (pVC49435) that was inactive.
Although deletion of the terminal amino acid, Lys-613, did not affect cytotoxicity, we suspected that other mutations in this position might affect cytotoxicity because of the low activity of various chimeric toxins in which the ligand was placed in peptide linkage at the carboxyl terminus of PE (ref.
11 and unpublished data). Therefore, Lys-613 was converted to glutamine, asparagine, or aspartic acid. Each of these mutations produced a less cytotoxic molecule (Table 5 ). 15 Mutant PE proteins were expressed in E. coli and purified from the periplasm. Analyses were as described in legends to Tables 1 and 2 . Tables 1 and 2 ). All the mutants had full ADP-ribosylation activity (100o that of PE). previously (9) . These uptake results were confirmed by a fluorescence increased without a decrease in cytotoxicity. Also shown in assay that measured the internalization of PE and various Table 6 is a PE molecule with RPHMPGDILK (pVC4715) at mutant PE molecules (Fig. 3) 
DISCUSSION
We have shown that mutations at the carboxyl end of PE and particularly in the last 5 amino acids of PE result in molecules with full ADP-ribosylation activity but greatly reduced cytotoxicity. Depending on the type of mutation introduced, cytotoxicity was often undetectable and at a minimum was decreased 6-fold. PE must undergo several steps in order to intoxicate a cell. These include (i) binding to a cell surface receptor, (ii) internalization via coated pits into endocytic vesicles and perhaps other endocytic compartments, (iii) translocation of a portion of PE into the cytosol, which probably requires proteolytic processing of PE, and finally (iv) ADP-ribosylation of elongation factor 2. Here we show that carboxyl-terminal mutants of PE have retained their capacity to bind to 3T3 cells ( Fig. 2) and to be taken up into endocytic vesicles (Fig. 3) . Furthermore, after 30 min of uptake there was no obvious difference in the pattern of the vesicles that contained PE or that contained several different carboxyl-terminal mutants of PE. This result indicates that the mutant toxins were located in the same intracellular compartment as native PE. Also, these mutants did not have any defect in ADP-ribosylation activity. Thus, the mutations at the carboxyl end of PE must affect some step occurring after internalization and before ADP-ribosylation. The most likely step affected by these mutations is the one in which PE is processed and translocated into the cytosol. The amino acid sequence at the carboxyl end of PE is Arg-Glu-Asp-Leu-Lys (REDLK, Table 2 ). Arg-609 can be replaced by lysine, but nonbasic amino acids cannot be tolerated (Table 3) . Lys-613 is not essential and can be deleted without loss of cytotoxic activity (Table 1) , but it cannot be replaced with a nonbasic amino acid (Table 5) . Thus, having either REDL or KEDLK at the carboxyl terminus produced a fully cytotoxic molecule (Table 4) . A search of the literature for similar sequences that were present in other molecules and performed a specific biological function revealed that the sequence which retains newly formed proteins within the endoplasmic reticulum is KDEL (19) . Therefore, we constructed several other mutant molecules, one of which contained the exact sequence previously described as being responsible for the retention of the protein in the lumen of the endoplasmic reticulum ( 
